Sichuan Hebang Biotechnology Corporation Limited
603077.SS · SHH
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | CN¥17 | CN¥14 | CN¥14 | CN¥16 |
| - Cash | CN¥7 | CN¥7 | CN¥7 | CN¥7 |
| + Debt | CN¥9 | CN¥8 | CN¥8 | CN¥7 |
| Enterprise Value | CN¥19 | CN¥15 | CN¥16 | CN¥17 |
| Revenue | CN¥2 | CN¥2 | CN¥2 | CN¥2 |
| % Growth | -8.6% | 27.2% | -0.5% | – |
| Gross Profit | CN¥0 | CN¥0 | CN¥0 | -CN¥0 |
| % Margin | 14.7% | 8.2% | 10.7% | -11.1% |
| EBITDA | CN¥0 | CN¥0 | CN¥0 | -CN¥0 |
| % Margin | 7.4% | 12.5% | 16.7% | -6.2% |
| Net Income | CN¥0 | CN¥0 | CN¥0 | -CN¥0 |
| % Margin | 2.1% | 1.8% | 0.7% | -11% |
| EPS Diluted | 0.004 | 0.004 | 0.001 | -0.02 |
| % Growth | 5.3% | 216.7% | 106% | – |
| Operating Cash Flow | CN¥0 | CN¥0 | -CN¥0 | CN¥0 |
| Capital Expenditures | -CN¥0 | -CN¥0 | -CN¥0 | -CN¥1 |
| Free Cash Flow | -CN¥0 | CN¥0 | -CN¥0 | CN¥0 |